We also searched for an eventual co-expression of epithelial-mesenchymal transition (EMT) markers with MARCKS expression in our institutional transcriptomics data of 71 IBC clinical samples [6]. This evidence concerns the gene MARCKS and inflammatory breast carcinoma.